DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $313,807 | -7.9% | 27,240 | -7.3% | 0.00% | 0.0% |
| Q4 2022 | $340,653 | -0.7% | 29,392 | +8.7% | 0.00% | 0.0% |
| Q3 2022 | $343,000 | +34200.0% | 27,030 | +17226.9% | 0.00% | – |
| Q2 2022 | $1,000 | -92.3% | 156 | -88.1% | 0.00% | – |
| Q1 2022 | $13,000 | -91.8% | 1,313 | -90.1% | 0.00% | -100.0% |
| Q4 2021 | $158,000 | +16.2% | 13,282 | +58.5% | 0.00% | 0.0% |
| Q3 2021 | $136,000 | +615.8% | 8,378 | +818.6% | 0.00% | – |
| Q2 2021 | $19,000 | -91.0% | 912 | -90.9% | 0.00% | -100.0% |
| Q4 2020 | $211,000 | – | 10,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |